Assenagon Asset Management S.A.
Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.
CIK 1546007
SENNINGERBERG, N4
Position in CRBP
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$800,459
-$729,502 QoQ
Shares Held
85,246
-54.6% QoQ
Ownership
0.441%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRBP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,940,218,245 across 69 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in CRBP
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $800,459 | 85,246 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,529,961 | 187,956 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $1,079,639 | 85,347 | Shares | Sole | 2025-10-07 | |
| 2024-09-30 | $4,563,025 | 221,184 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $10,803,844 | 238,759 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $10,181,053 | 259,456 | Shares | Sole | 2024-04-24 | |
| No filing history on record for this holder in this stock. | ||||||